Histiocytic Sarcoma in Renal Transplant Patients: a Literature Review

Overview

Journal J Med Case Rep

Publisher Biomed Central

Specialty General Medicine

Date 2023 Oct 2

PMID 37784161

Authors

Mahsa Salehi

Shafi Rehman

Miraa Qutab

Ruba Altheeb

Rashmi Prakash

Hamid Reza Jafari

Affiliations

Soon will be listed here.

Abstract

Background: Histiocytic sarcoma (HS) is defined as neoplasm resembling morphological and immunophenotypic characteristics of mature histiocytes. It is a rare form of lymphoid neoplasms. Despite advances in treatment and diagnosis of histiocytic sarcoma, majority of cases had poor prognosis due to progressive nature of the disease. In the following article, all reported cases of histiocytic sarcoma in renal transplant patients are reviewed.

Methods: In our literature review, all relevant reports were collected electronically by entering the necessary keywords. A Boolean approach using Medical Subject Heading (MeSH) keywords was implemented. After establishing the inclusion/exclusion criteria, article titles and abstracts were evaluated by Systematic Reviews and Meta-Analyses (PRISMA) standards for 2020. All cases of histiocytic sarcoma in renal transplant patients were included.

Result: Based on our inclusion and exclusion criteria 4 case reports were yielded in this review. Two were males and 2 were females with the mean age of 42.25 years. Fever was the most common symptom. Although tumor originated from the native kidney on one patient, the site of the primary tumor was thorax, oropharynx, and transplanted kidney in the rest. Metastasis was detected in all cases. Prednisone was used for all cases. EBV was positive in 2 cases and negative in one of them. Histology was diagnostic and similar in all cases. Immunohistochemistry was done for 3 cases. Although chemotherapy was done for 3 patients, all 4 cases ended in mortality.

Conclusion: Despite the fact that neoplasms are post renal transplant complications, histiocytic sarcoma is a scarce and fatal entity in such patients. Histological and immunohistochemistry tests are the corner stone in diagnosis of histiocytic sarcoma.

References

Takahashi E, Nakamura S . Histiocytic sarcoma : an updated literature review based on the 2008 WHO classification. J Clin Exp Hematop. 2013; 53(1):1-8. DOI: 10.3960/jslrt.53.1. View

Sabattini E, Bacci F, Sagramoso C, Pileri S . WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica. 2010; 102(3):83-7. View

Hornick J, Jaffe E, Fletcher C . Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol. 2004; 28(9):1133-44. DOI: 10.1097/01.pas.0000131541.95394.23. View

Castro E, Blazquez C, Boyd J, Correa H, de Chadarevian J, Felgar R . Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature. Pediatr Dev Pathol. 2009; 13(3):225-37. DOI: 10.2350/09-03-0622-OA.1. View

Yoshida C, Takeuchi M . Histiocytic sarcoma: identification of its histiocytic origin using immunohistochemistry. Intern Med. 2008; 47(3):165-9. DOI: 10.2169/internalmedicine.47.0386. View

Pollen M, El Jamal S, Lewin J, Manucha V . Histiocytic Sarcoma in a Kidney Transplant Patient: A Case Report and Review of the Literature. Case Rep Pathol. 2016; 2016:3591050. PMC: 5066022. DOI: 10.1155/2016/3591050. View

Aguiar P, Dias C, Azevedo P, Silva H, Almeida M, Pedroso S . Histiocytic sarcoma; case report of a rare disease in a kidney transplant recipient. J Nephropathol. 2015; 4(3):97-100. PMC: 4544561. DOI: 10.12860/jnp.2015.18. View

Tomlin J, Orosco R, Boles S, Tipps A, Wang H, Husseman J . Successful Treatment of Multifocal Histiocytic Sarcoma Occurring after Renal Transplantation with Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) Followed by Allogeneic Hematopoietic Stem Cell Transplantation. Case Rep Hematol. 2015; 2015:728260. PMC: 4475737. DOI: 10.1155/2015/728260. View

Kramer P, Prins M, KAPSENBERG J, Bornkamm G, Bijnen A, Rohol P . Persistent Epstein-Barr virus infection and a histiocytic sarcoma in a renal transplant recipient. Cancer. 1985; 55(3):503-9. DOI: 10.1002/1097-0142(19850201)55:3<503::aid-cncr2820550305>3.0.co;2-2. View

10.

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021; 10(1):89. PMC: 8008539. DOI: 10.1186/s13643-021-01626-4. View

11.

Boubenider S, Hiesse C, Goupy C, Kriaa F, Marchand S, Charpentier B . Incidence and consequences of post-transplantation lymphoproliferative disorders. J Nephrol. 1997; 10(3):136-45. View

12.

Penn I . Development of cancer as a complication of clinical transplantation. Transplant Proc. 1977; 9(1):1121-7. View

13.

Penn I . Tumors in allograft recipients. N Engl J Med. 1979; 301(7):385. DOI: 10.1056/NEJM197908163010716. View

14.

Penn I . Malignant lymphomas in organ transplant recipients. Transplant Proc. 1981; 13(1 Pt 2):736-8. View

15.

Purtilo D . Viruses, tumours, and immune deficiency. Lancet. 1982; 1(8273):684. View

16.

Pileri S, Grogan T, Harris N, Banks P, Campo E, Chan J . Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002; 41(1):1-29. DOI: 10.1046/j.1365-2559.2002.01418.x. View

17.

Bustami R, Ojo A, Wolfe R, Merion R, Bennett W, McDiarmid S . Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant. 2003; 4(1):87-93. DOI: 10.1046/j.1600-6135.2003.00274.x. View

18.

Opelz G, Dohler B . Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant. 2004; 4(2):222-30. DOI: 10.1046/j.1600-6143.2003.00325.x. View

19.

Lau S, Chu P, Weiss L . CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am J Clin Pathol. 2004; 122(5):794-801. DOI: 10.1309/QHD6-YFN8-1KQX-UUH6. View

20.

Wang E, Hutchinson C, Huang Q, Sebastian S, Rehder C, Kanaly A . Histiocytic sarcoma arising in indolent small B-cell lymphoma: report of two cases with molecular/genetic evidence suggestive of a 'transdifferentiation' during the clonal evolution. Leuk Lymphoma. 2010; 51(5):802-12. DOI: 10.3109/10428191003699845. View